KEY PRODUCTS
HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
01 1HTL Biotechnology
01 1SODIUM HYALURONATE, NATIVE (INTERMEDIATE, HMW AND VHMW)
01 1France
01 1Active
01 1Blank
HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34855
Submission : 2020-10-08
Status : Active
Type : II
20
Htl, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.
One of their notable products is SODIUM HYALURONATE, NATIVE (INTERMEDIATE, HMW AND VHMW), with a corresponding US DMF Number 34855.
Remarkably, this DMF maintains an Active status since its submission on October 08, 2020, highlighting commitment to regulatory compliance.
